Radiology - Technology Information Portal
Thursday, 21 November 2024
• Welcome to Radiology-TIP.com!
     • Sign in / Create account
 
 'Absorbed Dose Rate' 
SEARCH   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Searchterm 'Absorbed Dose Rate' found in 1 term [
] and 0 definition [
], (+ 1 Boolean[
] results
Result Pages :
Absorbed Dose Rate
The absorbed dose rate is the admitted dose per time unit.

See Absorbed Dose.
Omnipaque for Oral Use
Omnipaque (iohexol) is a nonionic, low-osmolar contrast agent and is also available for oral use, offering gastrointestinal (GI) visualization with minimal side effects. Omnipaque has a neutral taste that even kids will drink.
Orally administered iohexol is poorly absorbed from the normal gastrointestinal tract. Omnipaque is well tolerated and absorbed if leakage into the peritoneal cavity occurs.
The recommended dosage of undiluted Omnipaque (at a concentration of for example 350 mg/mL) for computed tomography of the abdomen in adults is 500 mL to 1000 mL, diluted to concentrations of 6 mg/mL to 9 mg/mL. The oral dose should be administered about 20 to 40 minutes prior to the CT scan.

Drug Information and Specification
NAME OF COMPOUND
Iohexol
MANUFACTURER
INDICATION
Bowel opacification
APPLICATION
Oral, rectal
CONCENTRATION
140, 240, 300 or 350 mg iodine
500 - 1000 mL of diluted solution
PREPARATION
Ready-to-use product, dilutable
STORAGE
Protect vials and glass or polymer bottles from strong daylight and direct exposure to sunlight. Do not freeze. Storage at controlled room temperature, 20°-25°C (68°- 77°F);
PRESENTATION
50, 75, 100, 125, 150, 200 or 250mL bottle or +PLUSPAK (polymer bottle)
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!
Result Pages :
 
Share This Page
Facebook
Twitter
LinkedIn

Look
      Ups
Radiology - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • Medical-Ultrasound-Imaging
Copyright © 2008 - 2024 SoftWays. All rights reserved.
Terms of Use | Privacy Policy | Advertising
 [last update: 2023-11-06 02:01:00]